2023
DOI: 10.1080/13880209.2023.2190777
|View full text |Cite
|
Sign up to set email alerts
|

Absolute oral bioavailability and possible metabolic pathway of panduratin A from Boesenbergia rotunda extract in beagle dogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…Such an approach minimizes the risk of adverse events, especially in patients with long COVID. Prior to the present study, a fingerroot extract formulation was developed and evaluated for its efficacy in SARS-CoV-2 infected hamsters, along with pharmacokinetics in healthy dogs [30] . Panduratin A has antiviral and anti-inflammatory activities and pinostrobin exerts good anti-inflammatory activity, but they have limited water solubility [8] , [12] .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Such an approach minimizes the risk of adverse events, especially in patients with long COVID. Prior to the present study, a fingerroot extract formulation was developed and evaluated for its efficacy in SARS-CoV-2 infected hamsters, along with pharmacokinetics in healthy dogs [30] . Panduratin A has antiviral and anti-inflammatory activities and pinostrobin exerts good anti-inflammatory activity, but they have limited water solubility [8] , [12] .…”
Section: Discussionmentioning
confidence: 99%
“…The procedure used to develop the fingerroot extract formulation was described by Boonyarattanasoonthorn et al . [30] .…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, the glucuronidation form of panduratin A was not detected in rats but could be found in dogs. 23 The differences in glucuronidation activity between species could be observed even between rodent species. 50 It is noteworthy that the potential biotransformation of Panduratin A has been observed to consist of Phase I metabolism, specifically oxidation.…”
Section: Discussionmentioning
confidence: 99%
“…In our previous study, healthy dogs were injected with 1 mg/kg/day of pure panduratin A and fed with 5 and 10 mg/kg/day of panduratin A-consisted fingerroot extract formulation that showed acceptable pharmacokinetic parameters and possible metabolic pathways. 23 Other research groups have reported pharmacokinetic studies of panduratin A in fingerroot extract using ethanolic extraction with 5–10% w/w in animal models. 24 However, there is a lack of information comparing oral administration of pure panduratin A and panduratin A-consisted fingerroot extract.…”
Section: Introductionmentioning
confidence: 99%